This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Petretta, M. Articles by Gisonni, P. Search for Related Content PubMed PubMed Citation Articles by Petretta, M. Articles by Gisonni, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Blood Pressure Medicines High Blood Pressure Hazardous Substances DB LISINOPRIL

(Hypertension. 1996;27:330-338.)
© 1996 American Heart Association, Inc.

Articles

Effect of 1 Year of Lisinopril Treatment on Cardiac Autonomic Control in Hypertensive Patients With Left Ventricular Hypertrophy

Mario Petretta; Domenico Bonaduce; Fortunato Marciano; Valter Bianchi; Giuseppe Valva; Claudio Apicella; Nicola de Luca; Pietro Gisonni

From the Institute of Internal Medicine, Cardiology and Heart Surgery, University of Naples "Federico II," and the National Research Council (CNR), Institute of Cybernetics (F.M.), Naples, Italy.

Correspondence to Domenico Bonaduce, MD, Via Aniello Falcone 394, 80127, Napoli, Italy.

Abstract In this study we evaluated in hypertensive patients the effects of drug-induced left ventricular hypertrophy regression on cardiac autonomic control, as assessed by means of heart period variability analysis. Power spectral analysis of 24-hour electrocardiographic monitoring was performed in 30 hypertensive patients with left ventricular hypertrophy at baseline, after 1 year of lisinopril treatment, and after 1 month of drug withdrawal. At the same times, patients underwent 24-hour blood pressure monitoring, echocardiographic study, and plasma renin activity assessment. Lisinopril treatment increased plasma renin activity and reduced 24-hour systolic and diastolic pressures (from 159±14 to 121±8 and from 103±7 to 80±3 mm Hg, respectively) and left ventricular mass index (from 159±33 to 134±26 g/m²); moreover, in 12 of 30 patients, left ventricular mass normalization was achieved. Drug withdrawal was followed by an increase in blood pressure without left ventricular mass modification. In the total study population, only high-frequency power was higher after lisinopril treatment. In the subgroup of patients with left ventricular mass normalization, daytime and nighttime high-frequency powers as well as nighttime total and very-low-frequency powers were higher after 1 year of treatment than at baseline. In the remaining 18 patients, power spectral measures after treatment were slightly lower than at baseline and were even lower after drug withdrawal. Thus, in hypertensive hypertrophic patients, lisinopril treatment improves sympathovagal imbalance when left ventricular mass normalization is achieved. In patients without left ventricular mass normalization, drug withdrawal is followed by a worsening of neural cardiac control.

Key Words: angiotensin-converting enzyme inhibitors • antihypertensive therapy • heart rate • hypertrophy

This article has been cited by other articles:

				C. W. McIntyre, S. G. John, and H. J. Jefferies Advances in the cardiovascular assessment of patients with chronic kidney disease NDT Plus, December 1, 2008; 1(6): 383 - 391. [Abstract] [Full Text] [PDF]